Trial Profile
A phase I trial of MNGX-100 for the treatment of naturally-occurring or surgically-induced menopausal syndrome
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Mar 2016
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Menopausal syndrome
- Focus Adverse reactions
- 11 Mar 2016 New trial record